In the biggest sign yet that the era of blockbuster drug is drawing to a close, Pfizer this week announced the creation of a new research unit focused on rare diseases.

One game-changer can deliver the promise of personalised healthcare. It is information technology, says Alan Davies of GE Healthcare.

Aberdeen University has opened a new £1.6 million centre for Marine Biodiscovery, to specialise in drug discovery based on compounds found in marine organisms.

The UK’s Motor Neurone Disease Association is funding its first stem cell research programme to develop models of the disease.